文献速递甲状腺疾病

下调的miR-125a-5p通过增加CD147水平促进甲状腺癌的糖代谢重编程和细胞恶性行为

Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
PubMed 文献 · Thyroid · 2018-04-10

该研究探讨了CD147在甲状腺癌进展中的分子机制及治疗价值。研究发现miR-125a-5p与CD147表达和功能呈负相关,miR-125a-5p通过直接抑制CD147蛋白表达来抑制有氧糖酵解和乳酸产生,从而降低甲状腺癌细胞的活力、迁移和侵袭。

要点

  • miR-125a-5p与CD147表达负相关,并调控其功能。
  • miR-125a-5p通过抑制CD147降低甲状腺癌细胞活力、迁移和侵袭。
  • CD147抑制可能是甲状腺癌的候选治疗靶点。

核心结论

  • miR-125a-5p与CD147之间的新联系提示miR-125a-5p具有新的诊断和预后作用,且CD147抑制可能是甲状腺癌治疗的候选靶点。

研究设计与样本

  • 研究分析了甲状腺癌组织中CD147水平与预后和疾病进展的关系,并使用microRNA微阵列和生物信息学方法鉴定CD147的microRNA调控因子,通过测量这些miRNA在甲状腺癌组织和细胞系中的表达和功能进行研究。

主要发现

  • miR-125a-5p调控CD147,并与其表达和功能呈负相关。
  • CD147敲低或增加miR-125a-5p表达显著降低了甲状腺癌细胞的活力、迁移和侵袭。
  • miR-125a-5p通过直接抑制CD147蛋白表达,抑制有氧糖酵解和乳酸产生,随后降低甲状腺癌细胞活力、迁移和侵袭,从而发挥抑癌功能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: CD147 contributes to increased aerobic glycolysis through which it promotes tumor growth. Accumulating evidence suggests that CD147 exerts a variety of functions in thyroid cancer (TC) progression but the molecular mechanisms and therapeutic value of CD147 remain unclear. METHODS: CD147 levels in TC tissues were analyzed to assess its relationship with prognosis and disease progression. A microRNA (miRNA) microarray and bioinformatics approach were used to identify microRNA regulators of CD147 through measurement of the expression and functions of these miRNAs in TC tissues and cell lines. Precursor miRNA-transfected cells were used to assess regulation of CD147 by miRNA. The effect of miRNA on TC cells via inhibition of glycolysis through CD147 targeting was also evaluated. RESULTS: We found that miR-125a-5p regulates CD147 and is negatively correlated with its expression and function. Moreover, CD147 knockdown or increased miR-125a-5p expression significantly reduced the viability, migration, and invasion of TC cells. Our mechanistic studies demonstrate that, through directly repressing the expression of the CD147 protein, miR-125a-5p suppresses aerobic glycolysis and lactate production and subsequently reduces TC cell viability, migration, and invasion, thereby exerting tumor suppressor functions. CONCLUSIONS: The novel connection identified between miR-125a-5p and CD147 suggests a new diagnostic and prognostic role for miR-125a-5p and that CD147 inhibition may be a candidate therapeutic target in the therapy of for TC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Huang P, Mao LF, Zhang ZP, et al. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer. Thyroid. 2018. PMID: 29634399. doi:10.1089/thy.2017.0401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。